ArticleOpen forum infectious diseases2026
Cerebrospinal Fluid Profiles Across Clinical Manifestations of Early European Lyme Neuroborreliosis.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early European lyme neuroborreliosis (LNB) presents with distinct clinical manifestations, but comparative data on cerebrospinal fluid (CSF) findings across these forms are limited. Methods: We conducted a retrospective study of 405 patients with confirmed early LNB treated at a single center between 2005 and 2025. Thirteen routine CSF parameters were analyzed across three main clinical manifestations-meningoradiculoneuritis (Bannwarth syndrome), cranial neuritis, and erythema migrans (EM)-associated meningitis-and in relation to the duration of neurological symptoms. Multivariate regression was used to assess independent associations. Results: Of 405 patients, 274 (68%) had Bannwarth syndrome, 82 (20%) cranial neuritis, and 49 (12%) EM-meningitis. CSF abnormalities differed significantly among groups and were most pronounced in Bannwarth syndrome and least marked in EM-meningitis. Patients with Bannwarth syndrome more frequently had positive borrelial serology and intrathecal antibody synthesis. CSF leukocyte counts, protein, and albumin increased during the first 4 weeks of disease and then stabilized, whereas immunoglobulin levels peaked around week 6. Longer duration of neurological symptoms was associated with higher lymphocyte proportion, increased protein levels, and elevated IgM and IgG concentrations. Multivariate analysis confirmed that clinical manifestation, symptom duration, age, and sex independently influenced CSF parameters. Conclusions: The three principal manifestations of early European LNB differ in the magnitude of CSF inflammation and blood-brain barrier dysfunction. Bannwarth syndrome is associated with the most pronounced intrathecal inflammatory response, whereas EM-associated meningitis represents a milder phenotype. CSF abnormalities evolve over time, underscoring the importance of early diagnostic evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.